Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modulation of the alternative complement pathways by beta 1 H globulin.

K Whaley, S Ruddy

    The Journal of Experimental Medicine
    |November 2, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Revolutionizing male contraception: Personal lubricants as a novel way to deliver the Human Contraception Antibody.

    bioRxiv : the preprint server for biology·2025
    Same author

    Novel case of combination antibiotic therapy for treatment of a complicated polymicrobial urinary tract infection with one organism harboring a metallo-β-lactamase (MBL) in a pregnant patient.

    IDCases·2024
    Same author

    Prevention and treatment of Clostridium perfringens epsilon toxin intoxication in mice with a neutralizing monoclonal antibody (c4D7) produced in Nicotiana benthamiana.

    Toxicon : official journal of the International Society on Toxinology·2014
    Same author

    Fatal subaxial dislocation of cervical spine in rheumatoid arthritis.

    British medical journal·2010
    Same author

    Hemolytic assay of the ninth complement component: elevation and depletion in rheumatic diseases.

    The Journal of experimental medicine·2009
    Same author

    In vivo evaluation of matrix pellets containing nanocrystalline ketoprofen.

    International journal of pharmaceutics·2002
    Same journal

    Regulation of solid tumors by the peripheral nervous system.

    The Journal of experimental medicine·2026
    Same journal

    Friend or foe? IFNλ drives fibrosis.

    The Journal of experimental medicine·2026
    Same journal

    BAd-looking or CHarming: The two faces of BACH2.

    The Journal of experimental medicine·2026
    Same journal

    Bridging veins govern discrepancy of CSF efflux into dura mater in mice.

    The Journal of experimental medicine·2026
    Same journal

    Chimeric allergen receptor regulatory T cells suppress birch pollen allergic airway inflammation.

    The Journal of experimental medicine·2026
    Same journal

    Interferon-λ drives renal fibrosis by coordinating epithelial-fibroblast crosstalk.

    The Journal of experimental medicine·2026
    See all related articles

    Human plasma contains C3b inactivator accelerator (A-C3bINA), identified as beta 1 H. This protein potentiates C3b inactivation and regulates complement pathways by binding EAC43.

    Area of Science:

    • Complement system immunology
    • Protein biochemistry

    Background:

    • C3b inactivator accelerator (A-C3bINA) was isolated from human plasma.
    • The protein was identified as beta 1 H, a known contaminant in C3 preparations.

    Purpose of the Study:

    • To characterize the physical and functional properties of beta 1 H.
    • To elucidate the role of beta 1 H in complement regulation.

    Main Methods:

    • Antiserum production and immunodiffusion.
    • Analytical and sucrose density gradient ultracentrifugation.
    • SDS-PAGE and Sephadex G200 gel filtration.

    Main Results:

    • Beta 1 H is a single polypeptide chain with significant carbohydrate content, exhibiting asymmetry.

    Related Experiment Videos

  • It potentiates C3b inactivation by C3b inactivator and limits alternative pathway convertase formation.
  • Beta 1 H accelerates the decay of hemolytic sites on EAC43bB and EAC43bBP.
  • Conclusions:

    • Beta 1 H is a crucial regulator of the complement system, acting synergistically with C3b inactivator.
    • Its precise mechanisms of C3b binding and alternative pathway inhibition require further investigation.